Delcath Systems's three largest insider shareholders as of June 18, 2026 are Steven A J Salamon (Director, 3.41Mn shares), Advisors, Inc. Rosalind (Director, 3.41Mn shares), Gil Aharon (Director, 3.41Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Vojo Vukovic | Chief Medical Officer | 168,882 | 0 | 13 Jun, 2025 |
| John Purpura | Chief Operating Officer | 41,526 | 0 | 17 Oct, 2023 |
| Advisors, Inc. Rosalind | - | 0 | 3,413,468 | 09 May, 2025 |
| Steven A J Salamon | - | 0 | 3,413,468 | 09 May, 2025 |
| John Richard Sylvester | - | 14,936 | 0 | 25 Nov, 2025 |
| Gil Aharon | - | 0 | 3,413,468 | 09 May, 2025 |
| Sandra Pennell | Chief Financial Officer | 77,018 | 0 | 06 Mar, 2026 |
| Kevin Muir | Gm Interventional Oncology | 18,582 | 0 | 19 Mar, 2024 |
| David L. Hoffman | Gen'L Counsel, Cco Secy | 74,330 | 0 | 19 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Mar, 2026 | Sandra Pennell | Common Stock | A | 5,533 | $9.04 | 77,018 | D | P |
| 06 Mar, 2026 | Sandra Pennell | Common Stock | A | 5,533 | $9.04 | 77,018 | D | P |
| 17 Feb, 2026 | Sandra Pennell | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Kevin Muir | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Vojo Vukovic | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Vojo Vukovic | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Martha S. Rook | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | David L. Hoffman | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | David L. Hoffman | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Martha S. Rook | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Sandra Pennell | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Kevin Muir | Stock Option (Right to Buy) | A | 56,500 | $0.00 | 56,500 | D | A |
| 17 Feb, 2026 | Sandra Pennell | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |
| 17 Feb, 2026 | David L. Hoffman | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |
| 17 Feb, 2026 | Vojo Vukovic | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |
| 17 Feb, 2026 | Kevin Muir | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |
| 17 Feb, 2026 | Martha S. Rook | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |
| 17 Feb, 2026 | Vojo Vukovic | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |
| 17 Feb, 2026 | Kevin Muir | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |
| 17 Feb, 2026 | Martha S. Rook | Restricted Stock Units | A | 28,250 | $0.00 | 28,250 | D | A |